Bioceltix S.A. (WSE: BCX)
Poland
· Delayed Price · Currency is PLN 68.00
-1.50 (-2.16%)
Sep 30, 2024, 9:37 AM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 342.25 million as of September 30, 2024. Its market cap has decreased by -0.14% in one year.
Market Cap
342.25M
Enterprise Value
322.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
68.00
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 342.25M, an increase of 197.51%. That is a compound annual growth rate of 45.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 27, 2024 | 342.25M | -7.91% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Krka, d. d. | 17.90B |
| NEUCA S.A. | 3.76B |
| Sopharma AD | 2.14B |
| Synektik Spólka Akcyjna | 1.62B |
| Celon Pharma S.A. | 1.47B |
| Ryvu Therapeutics S.A. | 1.21B |
| Voxel S.A. | 1.11B |
| Selvita S.A. | 1.04B |